Autolus Therapeutics (AUTL) Other Non-Current Liabilities (2021 - 2026)

Autolus Therapeutics (AUTL) has 5 years of Other Non-Current Liabilities data on file, last reported at $477000.0 in Q4 2025.

• Quarterly Other Non-Current Liabilities rose 11.97% year-over-year to $477000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $477000.0 (up 11.97% YoY) and the FY2025 annual result came in at $477000.0, up 11.97% from the prior year.
• Other Non-Current Liabilities grew to $477000.0 in Q4 2025, from $472000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $477000.0 in Q2 2025 to a low of $105000.0 in Q3 2022.
• A 5-year average of $296647.1 and a median of $357000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities fell 9.38% — and 2024, when it surged 258.77%.
• Tracing AUTL's Other Non-Current Liabilities over 5 years: stood at $128000.0 in 2021, then slipped by 9.38% to $116000.0 in 2022, then surged by 207.76% to $357000.0 in 2023, then climbed by 19.33% to $426000.0 in 2024, then gained by 11.97% to $477000.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $477000.0 (Q4 2025), $472000.0 (Q3 2025), and $477000.0 (Q2 2025), per Business Quant data.